A systematic review and economic evaluation of alendronate, etidronate, risedronate, raloxifene and teriparatide for the prevention and treatment of postmenopausal osteoporosis
- 1 June 2005
- journal article
- research article
- Published by National Institute for Health and Care Research in Health Technology Assessment
- Vol. 9 (22) , 1-160
- https://doi.org/10.3310/hta9220
Abstract
Health Technology Assessment Volume: 9, Issue: 22, Published in June 2005Keywords
Funding Information
- Health Technology Assessment Programme (01/58/01)
This publication has 0 references indexed in Scilit: